catadegbrutinib   Click here for help

GtoPdb Ligand ID: 13736

Synonyms: BGB-116673 | BGB116673 | compound 14 [WO2021219070A1]
Compound class: Synthetic organic
Comment: The chemical structure for catadegbrutinib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a Bruton tyrosine kinase (BTK) degrader with antineoplastic potential. A structure match in PubChem aligns catadegbrutinib with the company research code BGB-116673/BGB116673, and with a structure claimed in Beigene's patent WO2021219070A1 [1]. BGB116673 is a conjugate of a BTK inhibitor with an E3 ligase ligand. As a PROTAC class degrader the resulting molecule functions to recruit targeted proteins to E3 ubiquitin ligase for proteasomal degradation of wild type and mutated forms of the BTK protein.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 14
Hydrogen bond donors 3
Rotatable bonds 12
Topological polar surface area 171.29
Molecular weight 851.01
XLogP 2.59
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC(=CC=C1[C@@H](C)NC(=O)C2=NC(=NO2)C(C)(C)C)C3=NC=NC4=C3C=C(C5=CN=C(C=C5)N6CCN(CC6)CC7CCN(CC7)C8=CC=C(C=C8)N9CCC(=O)NC9=O)N4
Isomeric SMILES CC1=C(C=CC(=C1)C2=C3C=C(NC3=NC=N2)C4=CN=C(C=C4)N5CCN(CC5)CC6CCN(CC6)C7=CC=C(C=C7)N8CCC(=O)NC8=O)[C@@H](C)NC(=O)C9=NC(=NO9)C(C)(C)C
InChI InChI=1S/C47H54N12O4/c1-29-24-32(6-12-36(29)30(2)51-43(61)44-54-45(55-63-44)47(3,4)5)41-37-25-38(52-42(37)50-28-49-41)33-7-13-39(48-26-33)58-22-20-56(21-23-58)27-31-14-17-57(18-15-31)34-8-10-35(11-9-34)59-19-16-40(60)53-46(59)62/h6-13,24-26,28,30-31H,14-23,27H2,1-5H3,(H,51,61)(H,49,50,52)(H,53,60,62)/t30-/m1/s1
InChI Key ZSOLMVZWDSGPDD-SSEXGKCCSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
Ligand families/groups PROTACs, molecular glues and other degraders
IUPAC Name Click here for help
3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)phenyl]piperidin-4-yl]methyl]piperazin-1-yl]pyridin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide
International Nonproprietary Names Click here for help
INN number INN
13463 catadegbrutinib
Synonyms Click here for help
BGB-116673 | BGB116673 | compound 14 [WO2021219070A1]
Database Links Click here for help
CAS Registry No. 2736508-60-2 (source: WHO INN record)
GtoPdb PubChem SID 507750369
PubChem CID 166521972
Search Google for chemical match using the InChIKey ZSOLMVZWDSGPDD-SSEXGKCCSA-N
Search Google for chemicals with the same backbone ZSOLMVZWDSGPDD
Search PubMed clinical trials catadegbrutinib
Search PubMed titles catadegbrutinib
Search PubMed titles/abstracts catadegbrutinib
UniChem Compound Search for chemical match using the InChIKey ZSOLMVZWDSGPDD-SSEXGKCCSA-N
UniChem Connectivity Search for chemical match using the InChIKey ZSOLMVZWDSGPDD-SSEXGKCCSA-N